Please use this identifier to cite or link to this item:
|Title:||The potential relationship between QTc interval prolongation and ziprasidone treatment: Three cases|
|Authors:||Uludağ Üniversitesi/Tıp Fakültesi/Psikiyatri Anabilim Dalı.|
Eker, Salih Saygın
Sivrioğlu, Enver Yusuf
Neurosciences & neurology
Pharmacology & pharmacy
|Citation:||Eker, S. S. vd. (2009). "The potential relationship between QTc interval prolongation and ziprasidone treatment: Three cases". Journal of Psychopharmacology, 23(8), 993-996.|
|Abstract:||QTc interval prolongation may appear as a consequence of both typical and atypical antipsychotic treatments. Ziprasidone, which is effective in treating schizophrenia, is associated with QTc prolongation. Although the prolongation of QTc with ziprasidone treatment is often pronounced, there is a scarce number of cases reported about the relationship between ziprasidone and QTc prolongation. Of the three cases presented in this case series, two cases showed values exceeding 0.50 s with ziprasidone treatment.|
|Appears in Collections:||Scopus|
Web of Science
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.